FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/07/014999 [Registered on: 23/07/2018] Trial Registered Prospectively
Last Modified On: 08/01/2022
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) 
Study Design  Other 
Public Title of Study   Safety assessment of products on skin. 
Scientific Title of Study   Evaluation of dermatological safety of investigational products by primary irritation patch test on healthy human volunteers of varied skin types. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
D01-6Q29-ZC-JY18; Version 01; Dated 06/07/2018  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Siddheshwar Mathpati 
Designation  Investigator 
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd. 
Address  Mascot-Spincontrol India Pvt. Ltd. Unit 2, Neeru Silk Mills, Mathuradas Mill compound, N.M. Joshi Marg - Lower Parel, Mumbai,INDIA

Mumbai (Suburban)
MAHARASHTRA
400013
India 
Phone  022-43349191   
Fax    
Email  siddheshwar@mascotspincontrol.in  
 
Details of Contact Person
Scientific Query
 
Name  Mr Mohit Lalvani  
Designation  Study Director 
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd. 
Address  MASCOT-SPINCONTROL India Pvt. Ltd. Unit 2, Neeru Silk Mills, Mathuradas Mill compound, N.M. Joshi Marg - Lower Parel, Mumbai, INDIA

Mumbai (Suburban)
MAHARASHTRA
400013
India 
Phone  022-43349191   
Fax    
Email  mohit@mascotspincontrol.in  
 
Details of Contact Person
Public Query
 
Name  Mr Mohit Lalvani  
Designation  Study Director 
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd. 
Address  MASCOT-SPINCONTROL India Pvt. Ltd. Unit 2, Neeru Silk Mills, Mathuradas Mill compound, N.M. Joshi Marg - Lower Parel, Mumbai, INDIA

Mumbai (Suburban)
MAHARASHTRA
400013
India 
Phone  022-43349191   
Fax    
Email  mohit@mascotspincontrol.in  
 
Source of Monetary or Material Support  
Not Applicable 
 
Primary Sponsor  
Name  ITC Life Sciences Technology Centre 
Address  Peenya Industrial area, I Phase, Peenya Banglore , 560058, Karnataka, India. 
Type of Sponsor  Other [FMCG] 
 
Details of Secondary Sponsor  
Name  Address 
Not Applicable  Not Applicable 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Siddheshwar Mathpati  MASCOT-SPINCONTROL India Pvt. Ltd.  MASCOT-SPINCONTROL India Pvt. Ltd. Unit 2, Neeru Silk Mills, Mathuradas Mill compound, N.M. Joshi Marg - Lower Parel,Mumbai–400013, INDIA
Mumbai (Suburban)
MAHARASHTRA 
022-43349191

siddheshwar@mascotspincontrol.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethos- An Institutional Ethics committee (Mumbai)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Varied Skin Types 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  1.Perfume Spray (261) 2.Cologne Spray (958) 3.Perfume Spray (9056B) 4.Perfume Spray (SI 1204) 5.Body Wash (SO9647A) 6.Body Wash (SO9647B) 7.Soap (TSP 118-174A) 8.Soap (TSP 119-83) 9.Soap (TSP 119-86) 10.Talc (C225)  1.For Product 1to 4, are aerosol & will be applied by semi occlusive method. 2.For products 5 to 10 will be diluted & applied under occlusion. 
Comparator Agent  Sodium Lauryl Sulphate (SLS) 3% Solution  3% Solution 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  55.00 Year(s)
Gender  Both 
Details  Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….)
Subjects representing varied skin types (ideally equal representation of all 4 skin types – Oily, Normal, Dry and combination) Subjects willing to come for regular follow up and ready to follow instructions during the study period. 
 
ExclusionCriteria 
Details  For female : Being pregnant or breastfeeding or having stopped to breastfeed in the past three months, Having refused to give his/her assent by signing the consent form, Taking part in another study liable to interfere with this study Being diabetic,Being asthmatic,Having eczema, oriasis, lichen plan, vitiligo whatever the considered area, Having disorder of the healing
(whatever the considered area),Having a rhinitis, allergic conjunctivitis or rhinosinusitis 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Safety assessment of products  Baseline,0 hrs,24 hrs& 7 days. 
 
Secondary Outcome  
Outcome  TimePoints 
Not Applicable  Not Applicable 
 
Target Sample Size   Total Sample Size="24"
Sample Size from India="24" 
Final Enrollment numbers achieved (Total)= "24"
Final Enrollment numbers achieved (India)="24" 
Phase of Trial   N/A 
Date of First Enrollment (India)   28/07/2018 
Date of Study Completion (India) 14/08/2018 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) 14/08/2018 
Estimated Duration of Trial   Years="0"
Months="0"
Days="10" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   Not Applicable 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Evaluation of dermatological safety of investigational products by primary irritation patch test on healthy human subjects of varied skin types. Test products will be tested against control involving 24 subjects. Total duration is 10 days. 
Close